Journal
JOURNAL OF HEPATOLOGY
Volume 50, Issue 3, Pages 453-460Publisher
ELSEVIER
DOI: 10.1016/j.jhep.2008.06.010
Keywords
HCV; microRNA; Viral replication; Replicon cell; RISC
Categories
Funding
- Ministry of Health, Labour and Welfare or Japan
- Ministry of Education, Culture, Sports, Science and Technology of Japan
Ask authors/readers for more resources
Background/Aims: Hepatitis C virus (HCV) infection causes chronic hepatitis and hepatocellular carcinoma. Current anti-HCV therapies are based on interferon therapy, which is insufficiently effective. microRNAs (miRNAs) are non-coding RNAs that regulate gene expression, and they have recently been shown to play an important role in viral replication. Methods:An algorithm-based search for miRNAs that target the HCV genome yielded one miRNA, miR-199a*, with a sequence similar to the HCV genome that is conserved among HCV genotypes. Results: Overexpression of miR-199a* inhibited HCV genome replication in two cells bearing replicons (replicon cell) HCV-1b or -2a, however, miRNA inhibition by specific antisense oligonucleotide (ASO) accelerated viral replication. Prior transfection of immortalized hepatocytes which were infected with serum of HCV genotype 1b and 2a-infected patients, with miR-199a* reduced HCV RNA replication activity. Mutation in the miR-199a* target site in the replicon reduced the effect of the miR-199a*. HCV replicon RNA is accumulated to the RNA-induced silencing complex (RISC) when miR-199a* was overexpressed to the replicon cell. This antiviral effect by miR-199a* was independent of the interferon pathway. Conclusions:The results of this study suggest that miR-199a* directly regulates HCV replication and may serve as a novel antiviral therapy. (C) 2008 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available